Early HIV treatment key to avoiding brain atrophy
New study underlines importance of early screening and antiretroviral therapyWhile the human immunodeficiency virus (HIV) has largely dropped from news headlines since the 1990s, at the end of 2016 there were 36.7 million people living with the infection, and of those only 53 per cent had access to treatment. A new study underscores the neurological consequences of exposure to HIV without antiretroviral therapy.
The Neuro marks Parkinson’s Awareness Month
April is Parkinson’s Awareness Month, a time to give special attention to a disease that affects approximately 100,000 Canadians. As a centre for both research and clinical treatment of Parkinson’s disease (PD), the Montreal Neurological Institute and Hospital (The Neuro) offers many specialized services and opportunities to participate in research to PD patients.
April is Parkinson’s Awareness Month
Multidisciplinary care and cutting-edge research share space at The NeuroThe Montreal Neurological Institute and Hospital (The Neuro) is recognized worldwide for its research and clinical expertise in Parkinson’s disease (PD). PD is a motor neuron disease that is generally associated with old age, but people can also develop it in their thirties and forties.
The Neuro – A Major Force in Parkinson’s Disease Research and Treatment
The Neuro – A Major Force in Parkinson’s Disease Research and TreatmentFor many years, the Montreal Neurological Institute and Hospital (The Neuro) and the Research Institute of the McGill University Health Centre have conducted studies that have led to a greater understanding of the nature of Parkinson’s disease (PD). About 100,000 Canadians have PD, a motor neuron disease generally associated with old age, but which can also appear in a person’s thirties or forties.
Neuro researchers awarded over $4.5 M from CQDM, Brain Canada and the Ontario Brain Institute
Researchers from the Montreal Neurological Institute and Hospital at McGill University and the MUHC, have received a total of over $4.5 M in funding, for innovative projects to accelerate diagnosis and drug discovery for diseases of the brain, including Alzheimer’s.
April - Parkinson’s Disease Awareness Month
The Montreal Neurological Institute and Hospital - The Neuro, McGill University and the McGill University Health Centre, is at the forefront of Parkinson’s research and clinical care. Parkinson’s patients are seen at The Neuro’s Movement Disorders Clinic and the Montreal General Hospital. Approximately 100,000 Canadians have Parkinson’s disease.
The Neuro to introduce experimental drug treatment
